SEC Form 4 · accession 0000899243-16-012719
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Scott McDowell
Officer — Senior VP, Drug Discovery
Period of report
Feb 2, 2016
Accepted (ET)
Feb 4, 2016 · 8:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $9.08 | Feb 2, 2016 | A | 27,211 | A | — | Feb 1, 2026 | Common Stock | 27,211 | 27,211 | D |
Explanation of responses
- F1The shares subject to this option shall vest and become exercisable in 48 equal monthly installments with the first installment on February 1, 2016, such that this option is fully exercisable on January 1, 2020.
- F2Not applicable.